Q3 2023 Results Important cautionary statement regarding forward-looking statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, statements regarding: financial guidance for 2023 and medium-and long-term growth outlook; the expected revenues from BARDA over the life of the contract; expectations whether and when we will be able to manufacture SUBLOCADE, PERSERIS, or other Indivior products in house; expected revenues and expe ...

November 9, 2023 Strong Top-line Performance and Strategic Progress in Q3 2023 • Q3 2023 SUBLOCADE® Net Revenue (NR) of $167m, +55% versus Q3 2022 • FY 2023 SUBLOCADE NR now expected to be $610m to $630m (vs. $590m to $630m) • OPVEE® launched; U.S. Biomedical Advanced Research and Development Authority (BARDA) contract secured | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------|------------|------------|----------|-------------|-------------|------------| | Period to Se ...

Indivior PLC (INVVY) Q2 2023 Earnings Conference Call July 27, 2023 8:00 AM ET Company Participants Jason Thompson - Vice President of Investor Relations Mark Crossley - Chief Executive Officer Christian Heidbreder - Chief Scientific Officer Ryan Preblick - Chief Financial Officer Conference Call Participants James Vane-Tempest - Jefferies Max Herrmann - Stifel Paul Cuddon - Numis Securities Thibault Boutherin - Morgan Stanley Karl Burns - Northland Capital Markets Edward Thomason - Liberum Peter Testa - On ...

Q2/H1 2023 Results July 27, 2023 Important cautionary statement regarding forward-looking statements 2 This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, statements regarding: expectations regarding the cost to resolve the Group's legal proceedings and regulatory matters; strategies for value creation and operational goals; expected sales levels for particular products; product development pipeline and potential future products; ex ...

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated by the Market Abuse Regulation (EU) No.596/2014, as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). Upon the publication of this announcement, the inside information is now considered to be in the public domain. July 27, 2023 Strong H1 and Q2 2023 Financial Results; FY 2023 Guidance Raised • Q2 2023 SUBLOCADE® Net Revenue (NR) of $155m, +58% versus ...

Indivior PLC (INVVY) Q1 2023 Earnings Conference Call April 27, 2023 8:00 AM ET Company Participants Jason Thompson - Vice President of Investor Relations Mark Crossley - Chief Executive Officer Christian Heidbreder - Chief Scientific Officer Ryan Preblick - Chief Financial Officer Conference Call Participants Paul Cuddon - Numis Securities Thibault Boutherin - Morgan Stanley Max Herrmann - Stifel Financial Corp Jason Thompson Good morning, good afternoon, everyone. Before we begin, I need to remind everyon ...

Q1 2023 Results April 27, 2023 Important cautionary statement regarding forward-looking statements 2 2 This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, statements regarding the Indivior Group's financial guidance for 2023 and its medium- and long-term growth outlook; strategies for value creation; expectations for sales levels for particular products; expectations regarding the cost to resolve the Group's legal proceedings and re ...

Indivior PLC (INVVY) Q4 2022 Earnings Conference Call February 16, 2023 8:00 AM ET Company Participants Jason Thompson - Vice President of Investor Relations Mark Crossley - Chief Executive Officer Christian Heidbreder - Chief Scientific Officer Ryan Preblick - Chief Financial Officer Conference Call Participants Thibault Boutherin - Morgan Stanley James Vane-Tempest - Jefferies Christian Glennie - Stifel Operator Good day and thank you for standing by. Welcome to the Indivior Plc Full Year Results 2022 Con ...

Indivior PLC (INVVY) Q3 2022 Earnings Conference Call October 27, 2022 8:00 AM ET Company Participants Mark Crossley - CEO Ryan Preblick - CFO Conference Call Participants Thibault Boutherin - Morgan Stanley James Vane-Tempest - Jefferies Max Herrmann - Stifel Paul Cuddon - Numis Operator Good day, and thank you for standing by. Welcome to IndiviorÂ's Q3 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there'll be a question-and-answer sess ...

Indivior PLC Q3 2022 Results October 27, 2022 Mark Crossley Chief Executive Officer Forward-looking statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, statements regarding the Indivior Group's financial guidance for 2022 and its medium- and long-term growth outlook; expectations for profitable growth and for particular products; the planned additional US stock exchange listing; potential inorganic growth opportunities; e ...